Showing results (871-880 of 1,008) with videos related to

Sort By:
Pageof 101
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2023
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancerA J Rosenberg, C-Y Liao, T Karrison, et al.
Insect Biochemistry and Molecular Biology|September 24, 2018
RNAi targeting of rootworm Troponin I transcripts confers root protection in maizeElane Fishilevich, Andrew J Bowling, Meghan L F Frey, et al.
Thyroid : Official Journal of the American Thyroid Association|August 11, 2022
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)Marcia S Brose, Johannes W A Smit, Chia-Chi Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2008
NCCN Task Force Report: mTOR inhibition in solid tumorsRobert A Figlin, Elizabeth Brown, Andrew J Armstrong, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective StudyRavi Bandaru, Hailu Fu, Haizi Zheng, et al.
The Oncologist|June 6, 2018
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck CancerMaura L Gillison, George Blumenschein, Jerome Fayette, et al.
The Journal of Clinical Investigation|May 19, 2026
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancerRavi Bandaru, Hailu Fu, Haizi Zheng, et al.
Head & Neck|April 13, 2022
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitorPaul L Swiecicki, Emily Bellile, Keith Casper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2016
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaMatthew E Spector, Assuntina G Sacco, Emily Bellile, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2021
Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized TrialAhmed M Arzika, Ramatou Maliki, Amza Abdou, et al.
Pageof 101